Simultaneous Stem Cell/Kidney Transplantation Is Feasible with Haploidentical Donors
With the addition of high-dose cyclophosphamide to graft-versus-host disease prophylaxis, simultaneous stem cell/kidney transplantation is feasible for selected patients who have partially HLA-matched donors.